BiotechTube
Home/ENYO Pharma/Keltoum Medji, MBA
KM

Keltoum Medji, MBA

VP Finance and Strategic Development

ENYO Pharma

Therapeutic Areas

NephrologyHepatologyMetabolic Diseases

ENYO Pharma Pipeline

DrugIndicationPhase
Vonafexor (EYP001)Alport SyndromePhase 2

Leadership Team at ENYO Pharma

DJ
Dr Jacky Vonderscher, PhD
Co-founder and Chief Executive Officer
DP
Dr Pietro Scalfaro, MD, MBA
SVP Head of Clinical Development, Chief Medical Officer
DR
Dr Raphaël Darteil, PhD
SVP Head of non-clinical Development & Profiling
View full ENYO Pharma profile